{
  "(0, 0)": "radiopharmacology",
  "(1, 0)": "name",
  "(1, 1)": "investigation",
  "(1, 2)": "route of administration",
  "(1, 3)": "in - vitro / in - vivo",
  "(1, 4)": "imaging / non - imaging",
  "(2, 0)": "i123 - iodide",
  "(2, 1)": "thyroid uptake",
  "(2, 2)": "oral or iv",
  "(2, 3)": "in - vivo",
  "(2, 4)": "non - imaging",
  "(3, 0)": "i123 - iodide",
  "(3, 1)": "thyroid imaging thyroid metastases imaging",
  "(3, 2)": "oral or iv",
  "(3, 3)": "in - vivo",
  "(3, 4)": "imaging",
  "(4, 0)": "i123 - o - iodohippurate",
  "(4, 1)": "renal imaging",
  "(4, 2)": "iv",
  "(4, 3)": "in - vivo",
  "(4, 4)": "imaging",
  "(5, 0)": "i123 - mibg (m - iodobenzylguanidine)",
  "(5, 1)": "neuroectodermal tumour imaging",
  "(5, 2)": "iv",
  "(5, 3)": "in - vivo",
  "(5, 4)": "imaging",
  "(6, 0)": "i123 - fp - cit",
  "(6, 1)": "spect imaging of parkinson 's disease",
  "(6, 2)": "iv",
  "(6, 3)": "in - vivo",
  "(6, 4)": "imaging"
}